Atherosclerosis: More Than Just Cholesterol

Atherosclerosis is a disease process involving the gradual buildup of cholesterol, fatty substances, calcium, and other materials within the lining of arteries. The term comes from the Greek words athero, meaning “paste,” and sclerosis, meaning “hardening.”

These deposits—known as plaques—can narrow arteries and reduce blood flow. In some cases, plaques may rupture, triggering blood clot formation. These clots can enlarge to block an artery completely or break free and travel to other parts of the body.

How Reduced Blood Flow Affects the Body

The symptoms of atherosclerosis depend on which arteries are affected:

  • Leg arteries: Reduced circulation may cause leg pain during walking (claudication)

  • Heart arteries: Narrowing can result in chest pain (angina) or heart attack

  • Brain arteries: Reduced blood flow may cause transient ischemic attacks (TIAs), with symptoms such as weakness, numbness, slurred speech, or facial drooping—events that can precede stroke

  • Pelvic circulation: Erectile dysfunction may also be an early sign of impaired arterial blood flow

How Healthy Are the Arteries?

Atherosclerosis is often diagnosed only after blockages develop, but arterial damage can begin long before narrowing is detectable.

Common diagnostic tools include:

  • Doppler ultrasound, which compares blood pressure at different points in the body

  • Ankle–brachial index, comparing leg blood pressure to arm blood pressure

  • Angiography, which visualizes narrowed or blocked coronary arteries

  • CT scans and magnetic resonance angiography (MRA)

Importantly, arteries may already be stiff, inflamed, or undergoing early plaque formation before any obvious blockage appears.

Early plaque formation involves a process sometimes described as engorgement, in which cholesterol and other materials accumulate within the cells lining the artery wall. Research suggests that oxidative stress and inflammation play a key role in this early stage.

What About Cholesterol?

Conventional approaches to atherosclerosis have focused heavily on lowering total cholesterol levels, often using statin medications. While cholesterol management can be one component of cardiovascular risk reduction, it has become increasingly clear that cholesterol levels alone do not fully explain atherosclerosis risk.

Large studies have shown that cholesterol-lowering drugs may reduce cardiovascular events in some populations, but the overall risk reduction is modest for many individuals. This has prompted broader interest in additional factors that influence arterial health.

Statins are also associated with side effects in some people. The most common is muscle pain, which can limit physical activity. In rare cases, severe muscle breakdown (rhabdomyolysis) may occur, potentially affecting kidney or liver function. Digestive symptoms and changes in liver enzymes have also been reported. These risks highlight the importance of individualized decision-making and monitoring when such medications are used.

Supporting the Body When Statins Are Used

Some individuals taking statins experience muscle discomfort or gradual muscle loss over time. Research has explored whether certain nutrients may help support normal muscle and energy metabolism during statin therapy:

How Statins Work—and Natural Parallels

Statins reduce cholesterol production by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis. This same pathway is also responsible for producing CoQ10, which helps explain some of the muscle-related effects seen with statins.

Certain dietary and botanical compounds have been studied for their ability to influence cholesterol metabolism through related mechanisms, including:

These approaches may affect cholesterol handling in gentler ways, though effects vary and should not be assumed to replace medical therapy.

Why Standard Cholesterol Tests Are Incomplete

Traditional cholesterol panels measure:

  • Total cholesterol

  • LDL

  • HDL

  • Triglycerides

However, research shows that cholesterol particle size and number are more strongly linked with plaque formation than total cholesterol alone. Smaller, denser LDL particles are more likely to penetrate arterial walls and contribute to plaque formation.

Advanced lipid testing that includes particle size and particle number provides more meaningful insight into cardiovascular risk than standard panels alone.

Omega-3 fatty acids, in particular, have been associated with favorable changes in cholesterol particle characteristics.

CRP: Inflammation Matters

Inflammation plays a central role in atherosclerosis. C-reactive protein (CRP) is a blood marker used to assess systemic inflammation and has been linked with cardiovascular risk.

When assessing risk for heart attack or stroke, combining:

  • lipid particle analysis

  • inflammatory markers such as CRP

offers a more complete picture than cholesterol levels alone.

Integrative Support After Proper Diagnosis

Atherosclerosis is complex and requires professional evaluation. This information is intended to support informed discussion—not self-treatment.

Lifestyle and nutritional strategies often explored alongside medical care include:

  • Dietary patterns such as the Mediterranean diet

  • Monounsaturated fats (e.g., olive oil)

  • High intake of colorful fruits and vegetables

  • Avoidance of refined sugars, refined flour, and trans fats

  • Regular, moderate physical activity

Nutrients and compounds commonly discussed in research include:

  • Omega-3 fatty acids

  • Resveratrol and N-acetyl cysteine (NAC)

  • CoQ10 and carnitine

  • Vitamin K2

  • D-ribose

  • Niacin

  • EGCG (green tea extract)

  • Gamma tocopherol

  • Plant sterols

Each addresses different aspects of inflammation, oxidation, lipid handling, or energy metabolism.